System Transmission

Top Signal

100#1 JOB

Activity

2192Ripe

+952 today

System

Livenow

Terminal Asset View

stockNASDAQ

GNPX

$2.01+2.55%

Genprex Inc

Ripe

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

77Ripe

Live Analysis Active

Company Mission

Genprex Inc creates gene therapies designed to treat cancer by targeting specific genetic factors in patients. Doctors and hospitals use these treatments to offer personalized care that may be more effective than traditional methods. The company makes money through partnerships with research institutions and by selling approved drugs to healthcare providers.

GNP

Industry Context

This company operates in the biotechnology sector, focusing on innovative treatments for serious diseases like cancer. It competes with larger pharmaceutical firms by developing gene-based therapies, which are cutting-edge but risky due to regulatory hurdles. Success depends on clinical trial results and FDA approvals, making it a high-reward but volatile investment.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

81Matrix

Market Momentum

46.6— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Accelerating

Velocity Score

Accelerating

StaticOptimal FlowMax Vel

Trading Activity

0.5x— Normal Volume

Today's Change

2.55%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Price energy is building quickly for a potential move. Bullish alignment confirmed.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing GNPX across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 06:28 AM UTC

As-of As of 2026-03-16T06:12:57.182Z UTC (~15m delay).

Develops gene therapies for cancer treatment, aiming to earn revenue from drug sales and partnerships with pharmaceutical companies.

Price is compressing on the weekly chart near $0, suggesting potential volatility expansion soon. Watch for a breakout above this level.

No technical indicators available, but monitor if price holds above $0, signaling stability in a volatile biotech sector.

Industry trend toward personalized medicine is driving interest, with price testing $0, signaling growth potential. Watch for sector momentum.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...